“…CHF5633 is a novel synthetic clinical pulmonary surfactant preparation composed by two phospholipid species, dipalmitoyl phosphatidylcholine (DPPC) and palmitoyloleoyl phosphatidylglycerol (POPG), and synthetic analogues of the hydrophobic surfactant proteins SP-B and SP-C. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We described patients’ characteristics and clinical outcomes after ED visits with CHF vs. without CHF. Logistic regression models were used to estimate the association between these characteristics and CHF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Although congestive heart failure (CHF) is considered a risk factor for postoperative mortality, reliable quantification of the relationship between CHF and postoperative mortality risk is limited. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Qiliqiangxin (QLQX) capsules are a commonly used proprietary Chinese medicine for the adjuvant treatment of chronic heart failure (CHF) in China. In recent years, several randomized controlled trials (RCTs) have reported on the efficacy and safety of QLQX combined with sacubitril/valsartan for CHF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: For the base-case, VN resulted in incremental costs per patient of CHF 764’402 (VN: CHF 901’654, SoC: CHF 137’252), incremental blindness-free years of 7.67 (VN: 28.32, SoC: 20.65) and incremental QALYs of 6.73 (VN: 18.35, SoC: 11.62), leading to an incremental cost-effectiveness ratio of CHF 113’526 per QALY gained. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Out of 1,046 patients, 526 had CHF and 538 had no CHF. Among patients with CHF, all 526 had decompensated CHF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Aging and chronic heart failure (CHF) are responsible for the temporal inhomogeneity of the electrocardiogram (ECG) repolarization phase. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Rationale and Methods: Skeletal muscle derangements, potentially including mitochondrial dysfunction with altered mitochondrial dynamics and high reactive oxygen species (ROS) generation, may lead to protein catabolism and muscle wasting, resulting in low exercise capacity and reduced survival in chronic heart failure (CHF). We hypothesized that 8-week n-3-PUFA isocaloric partial dietary replacement (Fat = 5.5% total cal; EPA + DHA = 27% total fat) normalizes gastrocnemius muscle (GM) mitochondrial dynamics regulators, mitochondrial and tissue pro-oxidative changes, and catabolic derangements, resulting in preserved GM mass in rodent CHF [Myocardial infarction (MI)-induced CHF by coronary artery ligation, left-ventricular ejection fraction <50%]. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Here we investigate whether a leukocyte redistribution occurs in CHF and whether this effect is influenced by beta-blocker therapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Although congestive heart failure (CHF) patients typically present with abnormal auscultatory findings on lung examination, respiratory sounds are not normally subjected to additional analysis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: To report Medtronic experiences with the development of animal models for atrial fibrillation (AF) and chronic heart failure (CHF) using high-rate pacing for AF and microemboli for CHF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Cardiac sympathetic afferent reflex (CSAR) is enhanced in chronic heart failure (CHF) rats. The aim of this study is to determine the effect of IMD in the PVN on CSAR and its related mechanisms in CHF rats. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: To assess the impact of individualised, reconciled evidence-based recommendations (IRERs) and multidisciplinary care in patients with chronic heart failure (CHF) on clinical guideline compliance for CHF and common comorbid conditions. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Chronic heart failure (CHF) is an increasingly important health problem worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Chi-square tests were performed to test whether the distribution of identified risk factors varied across the CHF, NHIF and non-member households. RESULTS: There was a higher concentration of identified risk factors among CHF households compared to those of the NHIF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Plasma ANP and NT-proBNP concentrations in dogs with right-sided CHF were significantly higher than in healthy controls and those without right-sided CHF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Alterations in skeletal muscle function and architecture have been linked to the compromised exercise capacity characterizing chronic heart failure (CHF). However, how passive skeletal muscle force is affected in CHF is not clear. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Early detection and intervention for dysphagia is important in patients with congestive heart failure (CHF). However, previous studies have focused on how many patients with dysphagia develop CHF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Fluid retention is the main reason for the high hospitalization rate among patients with chronic heart failure (CHF). Given the lack of knowledge about fluid intake regulation and its consequences in patients with CHF, current guidelines do not provide clear direction for fluid management. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The successful therapies for preventing and reversing CHF progression are urgently required. One strategy under active investigation is to restore dysregulated myocardial calcium (Ca(2+)), a hallmark of CHF. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso